Adial Pharmaceuticals, Inc.

NASDAQ (USD): Adial Pharmaceuticals, Inc. (ADIL)

Last Price

1.07

Today's Change

+0.02 (1.90%)

Day's Change

1.00 - 1.07

Trading Volume

126,110

Overview

Market Cap

6 Million

Shares Outstanding

6 Million

Avg Volume

171,734

Avg Price (50 Days)

1.05

Avg Price (200 Days)

1.24

PE Ratio

-0.36

EPS

-2.94

Earnings Announcement

27-Mar-2025

Previous Close

1.05

Open

1.04

Day's Range

1.0 - 1.07

Year Range

0.77 - 4.17

Trading Volume

124,454

Price Change Highlight

1 Day Change

1.90%

5 Day Change

-2.73%

1 Month Change

4.90%

3 Month Change

1.90%

6 Month Change

-4.46%

Ytd Change

-38.86%

1 Year Change

-42.47%

3 Year Change

-98.50%

5 Year Change

-98.03%

10 Year Change

-98.94%

Max Change

-98.94%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment